Related Experiment Videos
Repeat thallium-201 SPECT in cerebral lymphoma
F Borggreve1, R A Dierckx, R Crols
1Department of Neurology, Middelheim General Hospital, Antwerp, Belgium.
Functional Neurology
|March 1, 1993
Summary
Thallium-201 brain SPECT aids in diagnosing primary cerebral lymphoma when CT scans fail. This imaging technique accurately reflects disease progression and treatment response, even when CT findings are misleading.
Area of Science:
- Nuclear medicine
- Oncology
- Neurology
Background:
- Primary cerebral lymphoma is a rare brain tumor.
- Diagnostic imaging is crucial for timely intervention.
- Computed tomography (CT) scans can sometimes miss or misinterpret early-stage tumors.
Observation:
- A non-immunosuppressed patient presented with symptoms suggestive of a brain tumor.
- Initial CT scans did not reveal the tumoral process.
- Thallium-201 SPECT imaging indicated tumoral invasion.
Findings:
- Thallium-201 SPECT demonstrated higher tumor uptake and an increased tumor-to-non-tumor ratio during corticosteroid treatment.
- CT scans showed a decrease in tumor volume under treatment.
- Scintigraphical findings correlated better with clinical progression and postmortem results than CT scans alone.
Implications:
- Thallium-201 brain SPECT is a valuable tool for diagnosing and monitoring primary cerebral lymphoma.
- This technique can provide crucial diagnostic information when conventional imaging is inconclusive.
- SPECT imaging offers a more sensitive indicator of treatment response in cerebral lymphoma.